First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 21.1% of the 1,710,000 shares held after it.
1 other insider bought within 30 days.
Insider activity: CEO/CFO Mikkelsen Robert E bought about $18.0K of TGCB on Mar 21, 2024, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.
4 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$10.7K
four quarters, 2023-04-01 to 2024-03-31
Revenue, TTM TGCB
FY Jun 2023
$0
FY Jun 2022
n/a
FY Jun 2021
$8.1K
FY Jun 2020
n/a
Mar 2024
$0
Dec 2023
$10.7K
Sep 2023
$0
Jun 2023
$0
Mar 2023
$0
Dec 2022
$0
Sep 2022
$0
Jun 2022
$0
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
-$383.3K
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
-226.6%
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-2,326%
TTM net income over average of 2023-03-31 and 2024-03-31
Return on assets TGCB
FY Jun 2023
-2,804%
FY Jun 2022
n/a
FY Jun 2021
-210.5%
FY Jun 2020
n/a
Mar 2024
-2,326%
Dec 2023
-4,214%
Sep 2023
-3,840%
Jun 2023
-2,804%
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
-163.7%
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
-449.1%
Sep 2022
-334.8%
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing TGCB
FY Jun 2023
n/a
FY Jun 2022
n/a
FY Jun 2021
n/a
FY Jun 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
6 not measured: Profitability, Financial health, Insider conviction, Institutional and government, Risk and compliance, US patents
Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; the filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
1 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.